Company / SG&A per Share
Wave Life Sciences Ltd. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.49
FY2025
5-year range
$0.49 / $0.87
FY2021-FY2025
Trend
-0.6%
vs FY2024
Sector context
#166 of 210
Health Care
What the data says
Wave Life Sciences Ltd.'s sg&a per share of $0.49 is lower than 79% of companies in the Health Care sector (FY2025). SG&A per Share has declined for 5 consecutive years, from $1.42 in FY2020 to $0.49 in FY2025.
Based on SEC 10-K filings.
0.49 in FY2025 with a 5-year CAGR of -19.1%.
Improved from $0.59 to $0.49 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -13.9%
- 5-Year CAGR
- -19.1%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 210This company $0.49 Sector average $40.75
▼
-98.8% below sector average
Key checks
Key Insights
- Wave Life Sciences Ltd.'s sg&a per share has declined for 5 consecutive years.
- In FY2025, sg&a per share decreased 0.6% year-over-year.
- Ranks #166 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.49 | -0.6% |
| FY2024 | $0.50 | -16.1% |
| FY2023 | $0.59 | -23.4% |
| FY2022 | $0.77 | -11.6% |
| FY2021 | $0.87 | -38.8% |
| FY2020 | $1.42 | +55.5% |
| FY2019 | $0.92 | -35.5% |
| FY2018 | $1.42 | +23.7% |
| FY2017 | $1.15 | +54.7% |
| FY2016 | $0.74 | +91.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026